Attovia Therapeutics - 5% or greater shareholders include Frazier Life Sciences Xi, alamar Holdco and deep track Biotechnology master fund

Attovia Therapeutics - 5% or greater shareholders include Frazier Life Sciences Xi, alamar Holdco and deep track Biotechnology master fund